Background/Aims: The aggressive property of ovarian cancer (OC) in terms of epithelialmesenchymal transition (EMT), proliferation and metastasis are of major concern. Different growth factors including TGFβ are associated with regulating these molecular events but the underlying mechanisms remain unclear. The aim of this report is to decipher the regulation of EMT by co-activation of TGFβ and Wnt signalling cascades in gaining malignancy. Methods: The expression of the different components of signalling events were analyzed by QPCR, Western blot, Immunofluorescence microscopy and flow cytometry. β-catenin promoter activity was checked by luciferase assay. Results: We observed reduced EMT in ovarian cancer cells upon co-activation with TGFβ1 and LiCl as shown by the expressions of epithelial/ mesenchymal markers and the EMT promoting factor, Snail1, accompanied by decrease in the invasion and migration of the cells compared to individual pathway activation. A detailed study of the mechanism suggested reduction in the β-catenin and p-GSK3b (Ser 9) levels to be the driving cause of this phenomenon, which was reversed upon co-activation with higher concentrations of LiCl. Conclusions: Therefore, tumourigenesis might be affected by the concentration of ligand/ growth factors for the respective signalling pathways activated in the tumour microenvironment and interaction between them might alter tumourigenesis.
Introduction
Epithelial Ovarian Cancer (EOC) is the fourth leading cause of gynaecological malignancy around the world [1] . Being asymptomatic in the earlier stages, the detection, mostly in FIGO Stage III, reveals its metastasis to various parts of the body, resulting in poor prognosis [2] .
EOCs are highly aggressive in nature and make up 70% of all ovarian cancers. Uncontrolled hyper-activation of different growth factor signalling cascades are evident in supporting cancer growth and metastasis [3] [4] [5] [6] [7] [8] [9] [10] . Extremely well regulated signalling network in the form of cross talks between different growth factor signalling pathways are common in the developing organs of the embryo [11, 12] . The same network exists in cancer [13] , but it is not well regulated and brings about malignancy in the same.
TGFβ pathway is one of the major pathways involved in development, responsible for regulating embryogenesis, maintaining adult tissue homeostasis, regulating proliferation, differentiation, apoptosis, and migration in different cell types. It is a homodimeric cytokine which functions by binding to cell surface receptors to activate the Regulatory Smads (Smad 2 or 3, depending on the cell type) proteins, which, with the help of the Co-Smad (Smad 4), translocate to the nucleus and act as cofactors for the transcription of target genes [14, 15] . Hyperactivation of the TGFβ pathway has been reported in many cancer types [10] . Again, it plays a dual role-in the early stages of tumour development, it suppresses tumour growth and induces apoptosis, but in the later stages, it mediates tumour progression by inducing Epithelial-Mesenchymal Transition (EMT), migration and invasion [14] .
TGFβ1, with the help of different mediators [16, 17] , is a known inducer of EMT, a dedifferentiating process in which the epithelial cells lose their cobblestone-shaped morphology and gains spindle-shaped mesenchymal morphology with formation of actin stress fibres, reduced cell-cell junctions, polarization disruption and increased cellular motility [18, 19] . Several other signalling pathways are also known to induce EMT [9, 20, 21] , Wnt signalling being one of them. Wnt functions by binding to the cell surface receptor Frizzled, which, in turn, inactivates Glycogen Synthase Kinase 3β (GSK3β), leading to stabilization of β-catenin [22] , which translocates to the nucleus and upregulates the transcription of its target genes, many of which induce EMT. Chemicals like Lithium chloride inhibits GSK3β and stabilizes β-catenin [23, 24] , thus activating Wnt signalling pathway.
In the tumour microenvironment, several different growth factors, cytokines and oncometabolites are present, which affect cancer progression through EMT, invasion and migration individually or in unison [13, 25, 26] . Therefore, it is important to investigate the co-activation of two different signalling pathways to check the fate of cancer cells in terms of progression. Previous reports suggest that Wnt and TGFβ promote EMT [27] [28] [29] . Considering background references regarding Wnt and TGFβ signalling cascades in EMT and ovarian cancer [28] [29] [30] , we wanted to study the effect of this co-activation in these processes to mimick a part of the signalling cascade functioning in the tumour microenvironment. In this report, we have shown the effect of the functioning of Wnt and TGFβ in unison in abrogating EMT.
Materials and Methods

Cell culture and treatments
Human ovarian adenocarcinoma cells SK-OV3 and OAW-42 (ATCC and Sigma respectively) were cultured under standard conditions in McCoy's 5A (Sigma) and DMEM (Gibco TM , Invitrogen, USA) respectively; both supplemented with 10% fetal bovine serum (FBS), 100 U/ml Penicillin G, 100 μg/ml Streptomycin (Gibco TM ). Cells were serum starved for 6 hrs prior to treatments with 10 ng/ml Human recombinant TGFβ1 (rh TGFβ1; Calbiochem, San Diego) to activate the TGFβ signalling pathway and 25 mM lithium chloride (LiCl) (Sigma-Aldrich; St Louis, USA) to activate the canonical Wnt signalling pathway or vehicles (0.1 % BSA in 1X PBS). Dual treatment involved treating the cells with both TGFβ1 and LiCl simultaneously. TGFβ receptor inhibitor (RI; Calbiochem) was used to block the TGFβ signalling pathway and Dickkopf1 (DKK1; R&D Biosystems) was used as an inhibitor for the Wnt signaling pathway. Addgene) or SuperFOPFlash (with mutant TCF4 reporter sites; plasmid 12457, Addgene). Transfection and dual luciferase assay was carried out in the 96 well Glomax luminometer (Promega) as previously described [29] .
Transient transfection and luciferase assay
RNA isolation and Quantitative Real-time PCR (q-PCR)
Total RNA was isolated from cell-lines using TRI reagent (Sigma-Aldrich) following standard protocol and were processed and analyzed as previously described [31] . The list of primers used with their respective sequences and Tm are listed in Table 1 .
Western blot analysis
Cell lysis and protein extraction were performed as described previously following 24 hours of treatment [32] and subjected to immunoblotting with primary antibodies (1:2000)-β-catenin, GSK3β, Axin, Claudin 7, Snail1, GAPDH, α-tubulin (Santa Cruz Biotechnology, Carlsbad, USA), Vimentin, N-cadherin, p-GSK3β (Ser 9), GSK3β, Histone H3 (Cell Signalling Technologies, USA). Secondary antibodies used were tagged with Horse Radish Peroxidase (HRP) and chemiluminiscence was detected on reaction with ECL detection reagent (Bio-Rad, Hercules, CA, USA) in a chemidetector (UVP). The images were quantified using the ImageJ software.
In vitro Invasion Assay
In vitro cell invasion was studied using Matrigel invasion chamber (BD Biosciences, Bedford, USA) following the manufacturer's guideline. In brief, 2.5x10 5 cells were seeded in the inserts of the Matrigel and treated with TGFβ1, LiCl or both. The invasion chamber was incubated at 37 o C in 5% CO2 atmosphere for 22 h and Matrigel invasion assay was performed. The values obtained were calculated using the number of invaded cells from three filters.
Wound Healing Assay
Ovarian cancer cells at high confluency were serum starved and wounding was performed by scraping through the cell monolayer with a 200 μl pipette tip. Medium and non-adherent cells were removed, and cells were washed twice with PBS, and fresh serum-free medium with TGFβ1, LiCl or both was added. Cells were permitted to migrate into the area of clearing for 24-72 hrs. Wound closure was monitored by visual examination under microscope and the rate of migration was quantified by the ImageJ software.
Immunofluorescence microscopy
Immunofluorescence was carried out as described previously [30] using the antibodies Claudin 7, Vimentin, Snail and β-catenin.
Flow cytometric intracellular antigen staining
Treated cells were fixed in ice-cold 70% ethanol followed by incubation at 4 o C for 30 min. and centrifugation at approximately 800g for 5 min. They were then permeabilized with 0.25% Triton-X, followed by incubation with 1:200 dilution primary Ab and 1:600 dilution secondary Ab conjugated to a fluorophore for 30 min and analyzed by flow cytometry. Analysis was carried out in the instrument LSR Fortessa (BD) with the help of FACS Diva software.
Statistical analysis
All data are expressed as mean ± S.E.M. represented by error bars. The experiments were repeated at least three times in duplicate. 
Results
EMT was reduced when the ovarian cancer cells were co-activated with TGFβ1 and LiCl
The status of EMT in TGFβ1/LiCl co-treated cells (OAW42) was measured by gene expression profile of different markers and was compared with that of individual treatments at different time points. Though numerous EMT-associated genes were analyzed, only few showed expression in our cell of interest and their time of expression varied in many cases. Upregulation of mesenchymal markers (Cdh2 and Vim) with downregulation of the epithelial markers (Cdh1 and Cld7) were observed in individual treatments, whereas, in dual treatment, EMT was abrogated as shown by q-PCR (Fig. 1A-B) , Western immunoblot analysis (Fig. 1C ) and immunofluorescence microscopy ( Fig. 1E ) in the downregulation of mesenchymal markers (Vimentin, N-cadherin) and upregulation of epithelial markers (Claudin 7, E-cadherin). Similar results were obtained in qPCR in another cell line SKOV3 (Fig.  1D) . Inhibition of the TGFβ pathway by the receptor inhibitor (RI) led to downregulation of the mesenchymal marker Vimentin, but further treatment with each ligand led to restoration of the same marker (Fig. 1F) . Similarly, downregulation of the Wnt signalling pathway by prior treatment with DKK1 led to downregulation of the mesenchymal marker N-cadherin (Fig. 1G) . α-tubulin was measured to ensure uniform loading.
The EMT promoting transcription factor, Snail is downregulated upon co-activation
When the TGFβ1 and Wnt signalling pathways are co-activated, the expression of the EMT-inducer Snail1 was downregulated compared to that in the activation of individual 
pathway, as measured by q-PCR ( Fig. 2A) , Western blot (Fig. 2B ) and flow cytometry (Fig.  2C) analyzes. α-tubulin was used as a loading control for the immunoblot. This was further supported by immunofluorescence microscopy, where Snail1 showed reduced nuclear translocation (Fig. 2D ) in OAW42 cells. Immunofluorescence microscopic studies showed reduced expression of Snail1 in SKOV3 cells in co-activation compared to individual activation (Fig. 2E ) of each pathway. siRNA mediated knockdown of Snail1 in the OAW42 cells led to gain of the epithelial characteristic, as observed by the expression of Claudin 7 by Western blot analysis, GAPDH being used as a loading control (Fig. 2F) . The primary downstream component β-catenin (i) from the whole cell lysate. This was followed by studying the levels of Axin (ii), p-GSK3β (Ser 9) (iii), total GSK3β (iv), GAPDH (v) being used as a loading control. Protein isolated from the cells under similar treatment conditions were separated into cytoplasmic and nuclear fractions. Each fraction was analyzed for the same set of proteins. β-catenin from both cytoplasmic (vi) and nuclear (xi) fractions were compared against the loading controls GAPDH (x) and Histone H3 (xii) respectively. Axin (vii), p-GSK3β (Ser9) (viii) and total (ix) bands were observed in cytoplasmic fractions only. 
Effect of the co-activation on invasion and migration of the ovarian cancer cells
Matrigel invasion assay (Fig. 3A) showed a decrease in the cell invasion index upon dual treatment with TGFβ1 and LiCl compared to individual treatment. The bar diagram shows data signifying cell invasion index with respective treatment. Migration studies conducted by scratch wound assay (Fig. 3B) showed complete or near complete wound closure in individual pathway activation, which was attenuated when both the pathways were activated. The bar diagram signifies the rate of migration (μm/24h) in case of singular or co-activation.
β-catenin levels determine the mechanism of EMT attenuation
Expression of β-catenin observed in Western blot analysis by activation of the Wnt signalling pathway by different doses of LiCl (25mM, 30mM, 35mM) with or without simultaneous induction of the TGFβ signalling pathway. α-tubulin was used as a loading control (Fig. 4A) . Comparison of dual treatment with individual treatments showed reduced β-catenin expression (total, cytoplasmic and nuclear, Fig. 4Bi, vi, xi respectively) , as shown by Western blot analysis. Total and cytoplasmic axin levels were decreased in dual treatment, but was considerably increased in individual treatment (Fig. 4Bii, vii) . Reduced β-catenin levels were accompanied by reduced p-GSK3β (Ser9) levels ( Fig. 4Biii and viii) , in the dual treatment compared to LiCl treatment alone. Total GSK3β was also measured (Fig. 4Biv, ix) . GAPDH was used as a loading control for total (Fig. 4Bv ) and cytoplasmic fractions (4Bx), whereas, Histone H3 was used as a loading control for nuclear fraction (Fig. 4Bxii) . Axin, p-GSK3β (Ser9) and GSK3β were absent in nuclear fractions. Western immunoblot analysis to show the absence of cytoplasmic fraction contamination in nuclear fraction and vice versa (Fig. 4C) , where GAPDH is a cytoplasmic marker and Histone H3 is the nuclear counterpart. Immunofluorescence microscopy (Fig. 4D) showed hindered nuclear localisation of β-catenin in the co-activated cells than that with individual activation. The luciferase assay (Fig. 4E) suggested decreased β-catenin promoter activity in the co-activated cells compared to the LiCl-treated cells. To ascertain the mechanism of action behind the reduction in β-catenin level, cells treated with higher concentration of LiCl (35mM) with or without TGFβ1 was analyzed, which showed higher β-catenin levels in dual treatment. This change in expression was concurrent with changes in the levels of p-GSK3β (Ser 9) (Fig. 4F) . The panel beside the Western blot images represent the respective band intensities (R.A.U.).
Discussion
Signalling aberrations in different cancer types are common and contribute majorly to tumourigenesis. TGFβ and Wnt, the master regulators of embryogenesis, are also known to induce the same functions [29, 33] , being upregulated in ovarian cancer [16, 17, 32] . Crosstalk between the two pathways is reported during developmental stages [11, 12, 27] , however, in cancer, though their interaction has been reported [13] , the exact effect on cancer progression is still not known. In this study, we aim to uncover this effect on ovarian cancer progression. Each pathway when separately activated, increased EMT, migration and invasion, whereas a dual activation reduced this effect. However, EMT and migration and invasion are well related [34, 35] . Cancer cells undergoing metastasis frequently show the phenomenon of EMT. We observed the mesenchymal markers N-cadherin and Vimentin to be upregulated, suggesting EMT induction upon individual treatment with each factor. However, the co-activation of the TGFβ and Wnt signalling pathways failed to demonstrate this change. An observation opposing the marker levels in EMT induction led us to believe decreased EMT upon dual activation.
EMT is brought about by the transcriptional promoters like Snail1/2, Zeb1/2 and Twist [34] . Snail1 is the earliest inducer of EMT reported [36] , which regulates the expressions of the genes responsible for promoting or inhibiting EMT [36, 37] . Reduced expression of SNAIL1 in co-activation of TGFβ and Wnt signalling suggested inhibition of EMT in this condition. Snail1-induced reduction of E-cadherin increases and stabilizes β-catenin, which then translocates to the nucleus, upregulating its target genes. Reduced Snail1, in conjunction with reduced β-catenin marked the EMT inhibition. Now, β-catenin is a key downstream component of the Wnt signalling pathway, where its stabilization is directly proportional to GSK3β phosphorylation at Ser9. To ascertain this fact, the experiments conducted corroborated the results with reduced p-GSK3β (Ser 9) levels in dual pathway activation compared to only LiCl treatment. The reduced axin levels in dual treatment suggested the less availability of the scaffold protein in comparison to individual treatment. Even the luciferase assay proved the reduced β-catenin promoter activity in co-activated cells. However, this effect was seen only at a particular range of LiCl concentration (25mM). At higher concentrations (viz. 35mM), p-GSK3β (Ser9) levels were increased that causes β-catenin level to increase, thus promoting metastasis. This sheds light on how some tumours remain benign, while others go on to become malignant.
Our study is not the first to report an event of this kind. Previous experiments in human bronchial fibroblasts (HBFs) from non-asthmatic patients showed that the differentiation from fibroblast to myofibroblast was enhanced upon lithium administration to the TGFβ-treated cells. However, this 'differentiation' process was inhibited in HBFs isolated from asthmatic patients, suggesting that the TGFβ-treated HBFs show opposing response to LiCl treatment indicating the inconsistent outcome of the interaction between TGFβ and Wnt signalling pathways [38] . Another study carried out in keloids and hypertrophic scars reported that TGFβ could activate and then inhibit the Wnt/β-catenin pathway in pathological scar formation. They also reported decrease in β-catenin levels under the influence of different TGFβ concentrations, suggesting that both synergism as well as antagonism exist in the interaction of these pathways [39] . Therefore, LiCl treatment and activation of Wnt signalling pathway could interfere with the TGFβ-mediated action in cancer and non-cancer cell types. In the present study, we got a similar observation. At present, the exact mechanism of this inhibitory activity of TGFβ as well as Wnt signalling pathways, when they are coactivated, may not be explained fully. However, it is possible that alteration or variation of concentrations or stoichiometry of different factors including growth factors in tumour microenvironment might significantly contribute in dysregulating the signalling events in cancer cells [39, 40] . Among many evidences, the present study is a very prominent one to show the cross-talk between two major pathways that might play differential roles in ovarian cancer progression, subject to their stoichiometry in tumour microenvironment (TME).
In conclusion, though several studies report on the interactions between the TGFβ and the Wnt signalling pathways, their cross-talk has been shown in this investigation to regulate oncogenic abilities of the ovarian cancer cells. It is possible that the relative concentration of ligands and/or inducers of different signalling pathways in the tumour microenvironment might act as deciding factors on whether or how these signalling events continue or culminate to regulate cancer progression. From our data it might be speculated that the differential expression of β-catenin in different concentrations of LiCl in conjunction with TGFβ might explain how a non-metastatic benign tumour gains metastatic potential to enhance malignancy. This claim can further be strengthened by measuring the serum TGFβ and β-catenin levels in patient cohorts ranging from normal to benign ovarian tumours to highly malignant cancers. Therefore, the concentration of ligands as well as the inducers of different signalling pathways present in the TME might possibly decide the fate of their cross-talks. At certain concentrations it might inhibit EMT/invasion and at others, it can favour these events. This background information may be of importance while considering the therapeutic aspects modulating these signalling events to reduce ovarian cancer progression.
